Exact Mass: 697.3451

A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis > J04AB - Antibiotics D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives Same as: D02549

Bz-Ile-glu-gly-arg-pna

4-{[({4-carbamimidamido-1-[(4-nitrophenyl)carbamoyl]butyl}-C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}-4-[(1-hydroxy-2-{[hydroxy(phenyl)methylidene]amino}-3-methylpentylidene)amino]butanoate

C32H43N9O9 (697.3184)

HEERQ

His-Glu-Glu-Arg-Gln

C27H43N11O11 (697.3143)

Tas-108

C39H55NO10 (697.3826)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent

Betalutin

C30H47N7O10S (697.3105)

D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies

25-acetylchaxamycin C

N-(2-aminophenyl)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide

C37H46F3N5O5 (697.3451)

CID 21775293

D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins

PC 20:4/7:3;O3

PC 20:5/7:2;O3

PC 27:7;O3

PE 18:4/12:3;O3

PE 22:4/8:3;O3

PE 22:5/8:2;O3

PE 30:7;O3

LNAPS 29:6;O

PS 18:4/11:2;O

PS 20:4/8:3;O2

C34H52NO12P (697.3227)

PS 20:5/8:2;O2

C34H52NO12P (697.3227)

PS 20:5/9:1;O

PS 28:7;O2

C34H52NO12P (697.3227)

PS 29:6;O

ST 27:3;O8;HexNAc

C35H55NO13 (697.3673)

QWF Peptide

C38H43N5O8 (697.3111)

QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM[1]. QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM[1].

9-benzyl-11,14,17,20-tetrahydroxy-18-(1h-indol-3-ylmethyl)-15-(2-methylpropyl)-1,7,10,13,16,19-hexaazatricyclo[19.3.0.0³,⁷]tetracosa-10,13,16,19-tetraene-2,8-dione

C38H47N7O6 (697.3588)

[(2s,8s,11s,14r,17s)-17-[(2r)-butan-2-yl]-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]acetic acid

C35H51N7O8 (697.3799)

(2s,3r,4r,5r,6r)-2,4,5-tris[(trimethylsilyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}oxan-3-yl 2-[1-(trimethylsilyl)indol-3-yl]acetate

2,4,5-tris[(trimethylsilyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}oxan-3-yl 2-[1-(trimethylsilyl)indol-3-yl]acetate

[1-(trimethylsilyl)indol-3-yl]methyl 2-{3,4,5,6-tetrakis[(trimethylsilyl)oxy]oxan-2-yl}acetate

(7e,13e,15e,17e,19e)-21-[(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-1,3,5,6,25-pentahydroxy-11,12-dimethyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid

C34H51NO14 (697.3309)

(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,21z)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1(29),2,4,9,19,21,23,25,27-nonaen-13-yl acetate

(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,21z)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1(29),2,4,9,19,21,23,25,27-nonaen-13-yl acetate

(2r)-3-hydroxy-2-{[hydroxy({5-hydroxy-2-[2-(2-{2-[(2s,3s)-2-hydroxy-3-methylpentanoyl]-1,2-diazinane-3-carbonyl}-1,2-diazinane-3-carbonyl)-1,2-diazinane-3-carbonyl]-1,2-diazinan-3-yl})methylidene]amino}-2-methylpropanoic acid

(2r)-3-hydroxy-2-{[hydroxy({5-hydroxy-2-[2-(2-{2-[(2s,3s)-2-hydroxy-3-methylpentanoyl]-1,2-diazinane-3-carbonyl}-1,2-diazinane-3-carbonyl)-1,2-diazinane-3-carbonyl]-1,2-diazinan-3-yl})methylidene]amino}-2-methylpropanoic acid

C30H51N9O10 (697.3759)

[1-(trimethylsilyl)indol-3-yl]methyl (2s,3r,4s,5r,6s)-4,5,6-tris[(trimethylsilyl)oxy]-2-{[(trimethylsilyl)oxy]methyl}oxane-3-carboxylate

(3s,9s,15s,18s,21s)-9-benzyl-11,14,17,20-tetrahydroxy-18-(1h-indol-3-ylmethyl)-15-(2-methylpropyl)-1,7,10,13,16,19-hexaazatricyclo[19.3.0.0³,⁷]tetracosa-10,13,16,19-tetraene-2,8-dione

C38H47N7O6 (697.3588)

(2s)-2-[(2s)-2-[(2e)-3-methoxy-n-methylbut-2-enamido]-3-(4-methoxyphenyl)-n-methylpropanamido]-n,4-dimethyl-n-[(2s,3s)-3-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl]pentanamide

(1r,3s,5r,6r,7z,11r,12s,13z,15z,17z,19z,21r,23s,24r,25s)-21-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,5,6,25-pentahydroxy-11,12-dimethyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid

(1r,3s,5r,6r,7z,11r,12s,13z,15z,17z,19z,21r,23s,24r,25s)-21-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,5,6,25-pentahydroxy-11,12-dimethyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid

C34H51NO14 (697.3309)

[1-(trimethylsilyl)indol-3-yl]methyl 4,5,6-tris[(trimethylsilyl)oxy]-2-{[(trimethylsilyl)oxy]methyl}oxane-3-carboxylate

(2s)-2-[(2s)-2-[(2e)-3-methoxy-n-methylbut-2-enamido]-3-(4-methoxyphenyl)-n-methylpropanamido]-n,4-dimethyl-n-[(2s,3s)-3-methyl-1-oxo-1-[(2s)-2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl]pentanamide

(2s)-2-[(2s)-2-[(2e)-3-methoxy-n-methylbut-2-enamido]-3-(4-methoxyphenyl)-n-methylpropanamido]-n,4-dimethyl-n-[(2s,3s)-3-methyl-1-oxo-1-[(2s)-2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl]pentanamide

2-[2-(3-methoxy-n-methylbut-2-enamido)-3-(4-methoxyphenyl)-n-methylpropanamido]-n,4-dimethyl-n-{3-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}pentanamide

(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1(29),2,4,9,19,21,23,25,27-nonaen-13-yl acetate

(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1(29),2,4,9,19,21,23,25,27-nonaen-13-yl acetate

[1-(trimethylsilyl)indol-3-yl]methyl 2-[(2r,3r,4s,5r,6r)-3,4,5,6-tetrakis[(trimethylsilyl)oxy]oxan-2-yl]acetate